Artificial intelligence is reshaping access to justice across the legal system, though experts warn its actual role may surprise those expecting courtroom drama. The technology is not replacing lawyers in the ways
CVS Health (CVS) is overhauling its direct-to-consumer weight management programme, cutting the price of MinuteClinic weight-management visits to just $29 per appointment. The healthcare giant is also rolling out pharmacist support across
More
The UK Supreme Court has unanimously allowed the appeal in Drelle v Servis-Terminal LLC [2026] UKSC 29, delivering a landmark ruling on cross-border insolvency. The decision confirms that a creditor may present
More
Law schools across the United States are confronting a deep financial reckoning after years of prioritising prestige over sustainable economic foundations. Cooley Law School, once ranked second nationally, has cut three-quarters of
More
ATI Inc (NYSE: ATI), the specialty materials and components manufacturer, delivered a robust set of second-quarter 2026 financial results that sent its shares climbing sharply. The strong performance reflects growing demand across
More
Britain’s two flagship stock indices have surged to record levels in 2026, reflecting renewed investor confidence in UK equities after years of relative underperformance. The FTSE 100, which tracks the largest companies
More
ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), has launched a new multichannel campaign called “Do It For Future You” aimed at encouraging people to act on their
More
Israeli technology companies are confronting one of the most demanding regulatory and geopolitical environments in the history of their participation in US capital markets. The Tel Aviv 35 Index hit record levels
More
Biglaw firms with more than 500 lawyers have cemented their position as the single largest employer of new law graduates in the United States, according to fresh data. The findings come from
More
The FTSE 100 and FTSE 250 indices have been reaching record levels in 2026, reflecting a broadly optimistic mood across UK equity markets. Despite the strong overall performance, experienced investors know that
More
AstraZeneca (AZN) and CSPC Pharmaceutical Group have signed a joint venture contract to construct a new-generation biologics manufacturing facility in Shijiazhuang, China. The agreement marks the third strategic deal the two companies
More